搜索临床试验以：MB-102-单剂量 130 mg 或 2 剂量 130 mg，间隔 12 小时
总计312个结果
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbH完全的
-
Juventas Therapeutics, Inc.未知
-
Human Genome Sciences Inc.GlaxoSmithKline完全的
-
Genuine Research Center, EgyptEva Pharma完全的
-
HighField Biopharmaceuticals CorporationTigermed Consulting Co., Ltd招聘中
-
Lundbeck Canada Inc.完全的慢性淋巴细胞白血病 | 惰性非霍奇金淋巴瘤加拿大
-
Idorsia Pharmaceuticals Ltd.终止
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLC完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
GlaxoSmithKline终止
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone Pharmaceuticals招聘中
-
Centre Hospitalier Universitaire de Saint Etienne招聘中
-
Stanford UniversityWashington University School of Medicine; Duke University; University of Washington; University... 和其他合作者邀请报名
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd完全的
-
Genzyme, a Sanofi Company终止
-
Merck Sharp & Dohme LLCPfizer完全的
-
McGill University Health Centre/Research Institute...招聘中
-
Vectura, Inc.Syneos Health终止
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
University of WashingtonCystic Fibrosis Foundation完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的